The clinical trials market is forecasted to experience strong growth, expanding from $92.63 billion to $158.1 billion between 2025 and 2034, driven by rising pharmaceutical and biotechnology R&D, chronic disease prevalence, and demand for innovative treatment…
The biologics CDMO market presents growth opportunities driven by increasing demand for cell and gene therapies, advancements in bioprocessing technologies, and the expansion of global manufacturing capacities. The rise in biosimilar pipelines and need for co…